Rosenblatt Securities Reiterates “Sell” Rating for CME Group (NASDAQ:CME)

CME Group (NASDAQ:CMEGet Free Report)‘s stock had its “sell” rating reissued by Rosenblatt Securities in a research note issued to investors on Thursday, Benzinga reports. They presently have a $187.00 price target on the financial services provider’s stock, up from their prior price target of $185.00. Rosenblatt Securities’ price objective points to a potential downside of 11.35% from the stock’s current price.

A number of other research analysts also recently issued reports on the company. Barclays boosted their price objective on CME Group from $225.00 to $226.00 and gave the company an “equal weight” rating in a research note on Monday, April 8th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $210.00 target price (down previously from $235.00) on shares of CME Group in a research note on Friday, April 5th. Argus raised their price target on CME Group from $225.00 to $245.00 and gave the company a “buy” rating in a report on Wednesday, March 6th. The Goldman Sachs Group lowered CME Group from a “neutral” rating to a “sell” rating and set a $195.00 price objective for the company. in a research note on Wednesday, January 3rd. Finally, Morgan Stanley lifted their target price on CME Group from $222.00 to $225.00 and gave the company an “equal weight” rating in a research note on Tuesday, April 9th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company. According to MarketBeat, CME Group has a consensus rating of “Hold” and a consensus price target of $217.80.

Read Our Latest Report on CME

CME Group Stock Down 0.8 %

Shares of CME Group stock opened at $210.94 on Thursday. CME Group has a twelve month low of $175.73 and a twelve month high of $223.80. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. The company’s 50 day moving average is $214.73 and its 200 day moving average is $211.90. The company has a market cap of $75.94 billion, a price-to-earnings ratio of 24.00, a price-to-earnings-growth ratio of 5.97 and a beta of 0.49.

CME Group (NASDAQ:CMEGet Free Report) last posted its quarterly earnings data on Wednesday, April 24th. The financial services provider reported $2.50 EPS for the quarter, beating analysts’ consensus estimates of $2.44 by $0.06. CME Group had a return on equity of 12.45% and a net margin of 56.84%. The company had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.48 billion. During the same quarter in the prior year, the business earned $2.42 earnings per share. CME Group’s revenue for the quarter was up 3.2% compared to the same quarter last year. Research analysts anticipate that CME Group will post 9.58 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in CME. Norges Bank bought a new stake in shares of CME Group in the 4th quarter valued at about $959,260,000. Capital Wealth Planning LLC purchased a new stake in shares of CME Group during the 4th quarter valued at $253,563,000. Capital World Investors boosted its position in shares of CME Group by 8.7% in the 4th quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock worth $3,072,654,000 after purchasing an additional 1,172,575 shares in the last quarter. Morgan Stanley grew its stake in CME Group by 31.5% during the 3rd quarter. Morgan Stanley now owns 4,858,967 shares of the financial services provider’s stock worth $972,863,000 after buying an additional 1,163,103 shares during the last quarter. Finally, AEGON ASSET MANAGEMENT UK Plc acquired a new position in CME Group during the 4th quarter valued at about $113,772,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

About CME Group

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.